Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 4/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | ELANE | P08246 | 1/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.54 |
| ▸ | ACR | P10323 | 1/20 | 0.54 |
| ▸ | TMPRSS15 | P98073 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | CASP3 | P42574 | 1/20 | 0.53 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.53 |
| ▸ | F2 | P00734 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | NSD2 | O96028 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL382507 | 1.00 | PARP10 (0.72) | PARP10KMT2AMEN1MAPTTDP1 | |
| SCHEMBL9663679 | 0.94 | PARP10 (0.81) | PARP10KMT2AMEN1MAPTTDP1 | |
| SCHEMBL8205435 | 0.91 | PARP10 (0.78) | PARP10KMT2AMEN1MAPTTDP1 | |
| SCHEMBL725405 | 0.91 | PARP10 (0.77) | PARP10KMT2AMEN1MAPTTDP1 | |
| SCHEMBL28343302 | 0.91 | PARP10 (0.62) | PARP10KMT2AMEN1MAPTTDP1 | |
| Hydrochloric Acid SCHEMBL16050040 | 0.89 | PARP10 (0.74) | PARP10KMT2AMEN1MAPTTDP1 | |
| SCHEMBL5676789 | 0.88 | PARP10 (0.72) | PARP10KMT2AMEN1MAPTTDP1 | |
| SCHEMBL622771 | 0.88 | PARP10 (0.72) | PARP10KMT2AMEN1MAPTTDP1 | |
| SCHEMBL10610456 | 0.88 | PARP10 (0.72) | PARP10KMT2AMEN1MAPTTDP1 | |
| SCHEMBL8206009 | 0.88 | PARP10 (0.72) | PARP10KMT2AMEN1MAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0648220-A1 | DEUTERATED NUCLEOSIDES | CHATTOPADHYAYA, Jyoti (SE) | 1995-04-19 | — | — | EP | claimed |
| CN-118355117-A | Oligonucleotide compositions and methods thereof | 波涛生命科学有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118139629-A | Compositions and methods for editing MECP2 transcripts | 波涛生命科学有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118139977-A | Double-stranded oligonucleotide compositions and methods relating thereto | 波涛生命科学有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-117965536-A | Oligonucleotide compositions and methods thereof | 波涛生命科学有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117794560-A | Stapled peptides and methods thereof | 弗格制药有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117412761-A | Antibody drug conjugates for delivery of cytotoxic agents using MATE technology | 拜奥海芬治疗学有限公司 | 2024-01-16 | — | — | CN | disclosed |
| CN-110023322-B | Novel bicyclic nucleosides and oligomers prepared therefrom | 伯尔尼大学 | 2023-10-27 | — | — | CN | disclosed |
| CN-116940679-A | Oligomeric compounds for dystrophin rescue in DMD patients by skipping of exon-51 | SQY治疗公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-108135921-B | Oligonucleotide compositions and methods thereof | 波涛生命科学有限公司 | 2023-10-17 | — | — | CN | disclosed |
| US-20040043951-A1 | Hydrogelation agents | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2004-03-04 | — | — | US | disclosed |
| CN-1134426-C | Method for preparing substituted benzodihydropyran derivative | ���ƻ�ѧ������˾ | 2004-01-14 | — | — | CN | disclosed |
| CN-1116292-C | Process for preparing benzodihydropyranol deriv. | BASF AG (DE) | 2003-07-30 | — | — | CN | disclosed |
| EP-1129207-A1 | CATALYTIC ANTIBODIES AND METHOD FOR PRODUCING CHROMANES BY CYCLIZATION WITH SAID ANTIBODIES | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-05 | — | — | EP | disclosed |
| CN-1264705-A | Method for preparing substituted benzodihydropyran derivative | BASF AG (DE) | 2000-08-30 | — | — | CN | disclosed |
| WO-2000028330-A1 | METHOD FOR SELECTING CATALYTIC ANTIBODIES | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-18 | — | — | WO | disclosed |
| WO-2000028063-A1 | CATALYTIC ANTIBODIES AND METHOD FOR PRODUCING CHROMANES BY CYCLIZATION WITH SAID ANTIBODIES | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-18 | — | — | WO | disclosed |
| WO-2000027884-A1 | ANTIBODIES, MINI-ANTIBODIES OR ANTIBODY FRAGMENTS BINDING TO VITAMIN E AND THE USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-18 | — | — | WO | disclosed |
| CN-1249306-A | Process for preparing benzodihydropyranol deriv. | BASF AG (DE) | 2000-04-05 | — | — | CN | disclosed |
| CN-1111249-A | TTTr as protective group in nucleotide synthesis | CIBA GEIGY AG (CH) | 1995-11-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040043951-A1 | Hydrogelation agents | H1-2, GNA11, H1-0 | PARP10 406/4885KMT2A 1901/4885MEN1 3848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.